Vision loss
should not be accepted as inevitable
We develop photonic systems that safely stimulate retinal cells and support repair processes, helping to preserve central vision and maintain independence for people living with macular degeneration.
We empower clinicians with photonic systems designed to support proactive vision preservation.
Beyond Generic Light Therapy
Bespoke treatment protocols optimise retinal stimulation beyond generic or fixed photobiomodulation.
Continuous Revenue
Generate sustainable recurring revenue with repeatable treatment cycles that scale linearly with patient volume.
Integrated Workflows
Seamlessly integrate therapy into existing clinical workflows without requiring dedicated space or fixed infrastructure.
AI
Automate clinical reporting and optimise decisions with integrated AI tools that reduce administrative burden.
Consistent Delivery
Continuous care models replace passive management, enabling ongoing engagement with therapy over time.
Capital - Light
Eliminate high upfront costs with a low-friction subscription model, ensuring immediate service profitability.
Partners
&
Advisors
 |  |
|---|---|
 |  |
 |  |
